Research Program and Theme
Cancer Technology and Data Science | Cancer Imaging
Research Focus
Wawrzyniec Dobrucki’s studies focus on developing multimodal imaging strategies to track myocardial and peripheral angiogenesis with targeted molecular imaging agents. His current research explores the effect of dietary modulation on prostatic neuroendocrine differentiation and anticancer treatment efficacy. He is currently a co-investigator for a study on breast cancer and cholesterol and a study on nanotherapeutics for cancer treatment. He demonstrates the importance of nanoparticle imaging agent size, chemical functionalization, and the feasibility of molecular imaging of cancer with various types of nanoparticles through his research. His research in imaging strategies will eventually lead to individualized programs for disease prevention through advanced diagnosis, risk stratification, and targeted therapies, resulting in more successful and efficient health care. View his research group’s website for more information.
Education
- Ph.D., Chemistry, Ohio University, 2003
Campus Affiliations
- Associate Head for Graduate Programs, Bioengineering
- Associate Professor, Bioengineering
- Associate Professor, Biomedical and Translational Sciences
- Neil and Carol Ruzic Scholar, Biomedical and Translational Sciences
- Associate Professor, Health Care Engineering Systems Center, Coordinated Science Lab
- Associate Professor, Beckman Institute for Advanced Science and Technology
- Affiliate, Carl R. Woese Institute for Genomic Biology